Trial Profile
A Phase I Trial of Palbociclib in Combination With Dexamethasone in Relapsed or Refractory Adult B-Cell Acute Lymphoblastic Leukemia (ALL)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Mar 2024
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Palbociclib (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 02 Jun 2022 Status changed from recruiting to completed.
- 07 Apr 2022 Planned primary completion date changed from 1 Sep 2021 to 1 May 2022.
- 03 Jun 2021 Planned primary completion date changed from 1 Apr 2021 to 1 Sep 2021.